Applicant, as named in the Orange Book
Keryx Biopharms
Next listed expiry: Auryxia on 21 Jul 2030. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Auryxia ferric citrate | ferric citrate | 205874 | 21 Jul 2030 | patent |
Recent events
- 25 Oct 2026Auryxia · First generic approved 11 Mar 2026
- 25 Oct 2026Auryxia · Generic approved 11 Mar 2026